Fastigial Nucleus Stimulation for Coronary Heart Disease
Status:
Enrolling by invitation
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
To observe the effects of fastigial nucleus stimulation on serum inflammation, oxidative
stress related factors, cardiac autonomic function and prognosis in patients with coronary
heart disease
Phase:
N/A
Details
Lead Sponsor:
Affiliated Hospital of North Sichuan Medical College